This post is from a suggested group
Monoclonal Antibody Therapy: A Targeted Breakthrough in Modern Medicine
Monoclonal antibody therapy has emerged as one of the most innovative and precise advancements in modern healthcare. Unlike traditional treatments that may affect healthy and unhealthy cells alike, monoclonal antibodies (mAbs) are engineered to target specific molecules involved in a disease process. This level of accuracy allows clinicians to address illnesses at their root cause, enhancing treatment outcomes while reducing unwanted side effects. Over the past few decades, monoclonal antibody therapy has transitioned from an experimental concept to a powerful and widely used medical tool that continues to reshape patient care.
At its core, monoclonal antibody therapy uses laboratory-made antibodies designed to mimic the body's natural immune response. Antibodies are proteins produced by the immune system to identify and neutralize harmful pathogens such as bacteria and viruses. However, in many diseases—especially cancer and autoimmune disorders—the body may not produce effective antibodies…